Also trades as: 2616.HK (HKSE) · $vol 8M
CSPHF OTC
CStone Pharmaceuticals
1W: +4.9%
1M: +10.4%
3M: +26.9%
YTD: -15.4%
1Y: -24.5%
3Y: +51.0%
5Y: -32.0%
$0.76
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.4B
-2.5% ▼
5Y CAGR: -18.4%
Total Liabilities
$667M
-35.2% ▼
5Y CAGR: -3.8%
Shareholders Equity
$617M
+69.6% ▲
5Y CAGR: -26.9%
Cash & Investments
$919M
+36.6% ▲
5Y CAGR: -23.0%
Total Debt
$349M
-2.0% ▼
5Y CAGR: +33.0%
Net Debt
-$405M
-1168.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $743M | $559M | $997M | $388M | $754M |
| Short-Term Investments | $984M | $483M | $52M | $285M | $165M |
| Cash & ST Investments | $1.7B | $1.0B | $1.0B | $673M | $919M |
| Net Receivables | $118M | $77M | $172M | $131M | $34M |
| Inventory | $61M | $22M | $109M | $286M | $117M |
| Other Current Assets | $0 | $76M | $0 | $0 | $44M |
| Total Current Assets | $2.0B | $1.2B | $1.3B | $1.1B | $1.1B |
| Property, Plant & Equip. | $188M | $207M | $153M | $131M | $83M |
| Goodwill & Intangibles | $71M | $160M | $173M | $161M | $150M |
| Long-Term Investments | -$980M | -$480M | $4M | -$276M | $12M |
| Other Non-Current Assets | $1.0B | $25M | $2M | $288M | $9 |
| Total Non-Current Assets | $314M | $392M | $332M | $304M | $245M |
| Total Assets | $2.3B | $1.6B | $1.7B | $1.4B | $1.4B |
| — Liabilities — | |||||
| Accounts Payable | $414M | $290M | $246M | $338M | $77M |
| Short-Term Debt | $31M | $9M | $106M | $61M | $192M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $10M |
| Other Current Liabilities | $74M | $210M | $92M | $180M | $231M |
| Total Current Liabilities | $933M | $946M | $850M | $682M | $510M |
| Long-Term Debt | $116M | $219M | $213M | $257M | $157M |
| Other Non-Current Liab. | $1M | $0 | $69M | $0 | -$74M |
| Total Non-Current Liabilities | $131M | $243M | $355M | $348M | $157M |
| Total Liabilities | $1.1B | $1.2B | $1.2B | $1.0B | $667M |
| — Equity — | |||||
| Common Stock | $796K | $802K | $860K | $860K | $999K |
| Retained Earnings | -$7.7B | -$8.7B | -$9.0B | -$9.1B | $0 |
| Accumulated OCI | $491M | $473M | $483M | $470M | $0 |
| Total Stockholders Equity | $1.2B | $449M | $457M | $364M | $617M |
| Total Liabilities & Equity | $2.3B | $1.6B | $1.7B | $1.4B | $1.4B |
| — Key Metrics — | |||||
| Total Debt | $174M | $286M | $363M | $356M | $349M |
| Net Debt | -$569M | -$272M | -$633M | -$32M | -$405M |
| Total Investments | $3M | $3M | $55M | $9M | $177M |